Want to see AU:AGN full AI Analyst Report?
Argenica Therapeutics Ltd (AGN) Financial Statements
Argenica Therapeutics Ltd Financial Overview
Argenica Therapeutics Ltd's market cap is currently $14.77M. The company's EPS TTM is $-0.01; its P/E ratio is -10.85; Argenica Therapeutics Ltd is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 3.21M | $ 2.60M | $ 1.75M | $ 259.10K |
| Gross Profit | $ 0.00 | $ 3.21M | $ 2.60M | $ 1.75M | $ 259.10K |
| Operating Income | $ -7.06M | $ -7.68M | $ -5.67M | $ -6.62M | $ -4.09M |
| EBITDA | $ -7.06M | $ 0.00 | $ -1.90M | $ -1.32M | $ -257.41K |
| Net Income | $ -1.37M | $ -7.17M | $ -5.48M | $ -4.82M | $ -4.09M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 6.36M | $ 10.56M | $ 15.91M | $ 9.34M | $ 8.91M |
| Total Assets | $ 6.52M | $ 11.04M | $ 16.38M | $ 9.54M | $ 9.04M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -6.36M | $ -10.56M | $ -15.91M | $ -9.29M | $ -8.91M |
| Total Liabilities | $ 614.55K | $ 3.80M | $ 2.43M | $ 1.87M | $ 735.91K |
| Stockholders' Equity | $ 5.90M | $ 7.24M | $ 13.95M | $ 7.67M | $ 8.31M |
| Cash Flow | |||||
| Free Cash Flow | $ 0.00 | $ -5.70M | $ -5.06M | $ -3.30M | $ -3.36M |
| Operating Cash Flow | $ -4.19M | $ -5.70M | $ -5.06M | $ -3.30M | $ -3.36M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 50.00K | $ -50.00K | $ 0.00 |
| Financing Cash Flow | $ -2.94K | $ 346.90K | $ 11.63M | $ 3.73M | $ 5.13M |
Currency in AUD